-26.4% · 90d
$0.78
-0.01 (-1.00%)
News
(1)April 2026
Evogene Ltd. — 6-K Filing
EVGNEvogene Ltd.
# 🧾 What This Document Is This is a **6-K form**, which is a current report that foreign companies listed on U.S. exchanges must file with the SEC to announce major news. In this case, the "news" is official notification from the Nasdaq stock exchange that Evogene's stock price is too low. 👉 **Wh
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%